|
|
New hope in the discovery of eye disease early

Researchers reported that the new technique of spectral images of the retina may help doctors to diagnose glaucoma (cataract on the eye) in the early stages by observing changes in the blood vessels in the eye.
The researchers said Heriot Watt University, who developed spectral imaging technique, it may help in diagnosing the disease early.
The researchers presented details of the new technology to the Institute of Physics conference in Glasgow.
It is estimated that the number of visually impaired in the world will arrive in 2020 to about 200 million people, which can be avoided by 80 percent in the case of the use of new technology to detect the disease in the early stages of glaucoma.
The spectral imaging technique uses a standard ophthalmoscope, which have been modified so you can capture images of the retina at specific wavelengths.
It shows how oxygenated the blood flowing out of the retina.
The doctors said that early detection allows doctors to search for the cause of this problem.
The images are captured through a sophisticated digital camera and image processor corrects the eye movements when capturing images so as to collect a large number of images to get the best possible picture.
Dr. Andrew Harvey, who helped develop the technique, told BBC News Online: "This technique is safe, fast, simple and totally non-invasive, therefore, the periodic inspection every four months will not hurt the patient."
He added that the current screening methods of the eye can make the patient feel pain and sometimes cause side effects.
He said Harvey, saying: "We used this technique so far to capture images of the retina properly, and it seems that the images are extremely successful in helping doctors to detect disease glaucoma. We are now at an experimental stage but we hope that this technology doctors in the diagnosis and disease monitoring large that infect the eye. "
Natasha said Ed adviser at the Institute of British Sugar: "This technology is still at the stage of clinical trials, but we are all following it very closely. We welcome all of what defines the disease in the early stages. It is known that glaucoma is one of the leading causes of blindness in adults."

Researchers reported that the new technique of spectral images of the retina may help doctors to diagnose glaucoma (cataract on the eye) in the early stages by observing changes in the blood vessels in the eye.
The researchers said Heriot Watt University, who developed spectral imaging technique, it may help in diagnosing the disease early.
The researchers presented details of the new technology to the Institute of Physics conference in Glasgow.
It is estimated that the number of visually impaired in the world will arrive in 2020 to about 200 million people, which can be avoided by 80 percent in the case of the use of new technology to detect the disease in the early stages of glaucoma.
The spectral imaging technique uses a standard ophthalmoscope, which have been modified so you can capture images of the retina at specific wavelengths.
It shows how oxygenated the blood flowing out of the retina.
The doctors said that early detection allows doctors to search for the cause of this problem.
The images are captured through a sophisticated digital camera and image processor corrects the eye movements when capturing images so as to collect a large number of images to get the best possible picture.
Dr. Andrew Harvey, who helped develop the technique, told BBC News Online: "This technique is safe, fast, simple and totally non-invasive, therefore, the periodic inspection every four months will not hurt the patient."
He added that the current screening methods of the eye can make the patient feel pain and sometimes cause side effects.
He said Harvey, saying: "We used this technique so far to capture images of the retina properly, and it seems that the images are extremely successful in helping doctors to detect disease glaucoma. We are now at an experimental stage but we hope that this technology doctors in the diagnosis and disease monitoring large that infect the eye. "
Natasha said Ed adviser at the Institute of British Sugar: "This technology is still at the stage of clinical trials, but we are all following it very closely. We welcome all of what defines the disease in the early stages. It is known that glaucoma is one of the leading causes of blindness in adults."
0 Comments:
Post a Comment